Literature DB >> 4400527

Effect of receptor blocking drugs on the depletion of brain glycogen by amphetamine.

D A Hutchins, K J Rogers.   

Abstract

1. Amphetamine sulphate (5 mg/kg), administered intraperitoneally, reduces the concentration of glycogen in the mouse brain by 25-30% after 30 minutes.2. The effect of several receptor blocking drugs on the amphetamine-induced cerebral glycogenolysis was studied.3. DL-Propranolol (0.25 mg/kg) and pronethalol (10 mg/kg) antagonized the depletion of brain glycogen by amphetamine.4. Phentolamine, methysergide, atropine and mepyramine failed to antagonize the amphetamine-induced glycogenolysis.5. D-Propranolol, chlorpromazine and phenoxybenzamine antagonized the glycogenolytic effect of amphetamine only when administered in sedative doses.6. It is concluded that amphetamine-induced glycogenolysis in the mouse brain may be mediated through a beta-adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4400527      PMCID: PMC1665784          DOI: 10.1111/j.1476-5381.1971.tb07181.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  EFFECT OF DRUGS ON THE UPTAKE, RELEASE, AND METABOLISM OF H3-NOREPINEPHRINE IN THE RAT BRAIN.

Authors:  J GLOWINSKI; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1965-07       Impact factor: 4.030

2.  NEUROHORMONE LEVELS IN BRAIN AFTER CNS STIMULATION INCLUDING ELECTROTHERAPY.

Authors:  C BREITNER; A PICCHIONI; L CHIN
Journal:  J Neuropsychiatr       Date:  1964-02

3.  The action of chlorpromazine on diencephalic sympathetic activity and on the release of adrenocorticotrophic hormone.

Authors:  M HOLZBAUER; M VOGT
Journal:  Br J Pharmacol Chemother       Date:  1954-12

4.  The effect of adrenergic blocking agents on some metabolic actions of catecholamines.

Authors:  S MAYER; N C MORAN; J FAIN
Journal:  J Pharmacol Exp Ther       Date:  1961-10       Impact factor: 4.030

5.  Receptor mechanisms in the hyperglycaemic response to adrenaline in man.

Authors:  A Antonis; M L Clark; R L Hodge; M Molony; T R Pilkington
Journal:  Lancet       Date:  1967-05-27       Impact factor: 79.321

6.  The central mechanisms of phenothiazine compounds.

Authors:  R Y Ilyutchenok
Journal:  Agressologie       Date:  1968 Mar-Apr

7.  Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain.

Authors:  H Nybäck; G Sedvall
Journal:  J Pharmacol Exp Ther       Date:  1968-08       Impact factor: 4.030

8.  Hepatic glycogen and blood glucose control.

Authors:  P I Adnitt
Journal:  Biochem Pharmacol       Date:  1969-10       Impact factor: 5.858

9.  A comparison of the effects of (plus of minus)-propranolol and (plus)-propranolol in anaesthetized dogs; beta-receptor blocking and haemodynamic action.

Authors:  A M Barrett
Journal:  J Pharm Pharmacol       Date:  1969-04       Impact factor: 3.765

10.  THE EFFECT OF FASTING ON THE HYPERGLYCAEMIC RESPONSES TO CATECHOL AMINES IN RATS.

Authors:  W W FLEMING; A D KENNY
Journal:  Br J Pharmacol Chemother       Date:  1964-04
View more
  4 in total

1.  L-Dopa feeding suppression: effect on catecholamine neurons of the perifornical lateral hypothalamus.

Authors:  S F Leibowitz; C Rossakis
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

2.  Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.

Authors:  D A Hutchins; K J Rogers
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

3.  The effect of pargyline and desmethylimipramine on monoamine concentrations and amphetamine-induced glycogenolysis in the mouse brain.

Authors:  D A Hutchins
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

4.  Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds.

Authors:  Nader D Halim; Barbara K Lipska; Thomas M Hyde; Amy Deep-Soboslay; E Michael Saylor; Mary M Herman; Jay Thakar; Ajay Verma; Joel E Kleinman
Journal:  J Neurosci Methods       Date:  2007-11-29       Impact factor: 2.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.